KROS Chart
- 52-Week Range: $29.27 - $67.04
- Market Capitalization: $874.15M
- Short Percentage: 0%
- Target Price: $86.25
- Shares Outstanding: 24.03M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
KROS released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Keros Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare ConferenceGlobeNewsWire | February 11th
- Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2021 Financial ResultsGlobeNewsWire | November 4th
- Keros Therapeutics Appoints Simon Cooper, M.B.B.S. as Chief Medical OfficerGlobeNewsWire | August 2nd
Company Info
Website: https://www.kerostx.com
Address: 99 Hayden Avenue, Lexington, MA, United States, 02421
Sector: Healthcare
Industry: Biotechnology
Full time employees: 60
Address: 99 Hayden Avenue, Lexington, MA, United States, 02421
Sector: Healthcare
Industry: Biotechnology
Full time employees: 60
$KROS added
$KROS I actually want the market pullback 5% is pretty crazy how this market keep going and going
$KROS getting this mare ready to run today
$KROS added
$KROS now I buy
$KROS LETS GOOOOOOOO!!!!!!!
$KROS what V recovery or fake pump
$KROS still waiting to short this. Next Tuesday feels right for some reason
$KROS Burn burn burn
$KROS this will breakout Monday